Technology that generates 3D tumour twins that mimic the behaviour and characteristics of the original tumour
PreComb Therapeutics has raised €1.3M across 1 funding round from 3 investors, most recently a Seed round in Oct 2022. Based in Hombrechtikon, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-04 | Seed |
| €1.3M |
| Kinled Holding,LongeVC,Private Investors |
| View deal → |
